Skip to Main Content

Paper Details

CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory.
Cancer Discov
56
2021
CDK4/6, T-cell, cancer, chimeric antigen receptor, chimeric antigen receptor T cells, cyclin-dependent kinases 4 and 6, hormone receptor-positive breast cancer, immunologic T, melanoma, mice, patients, retinoblastoma, tumor
Author NameAffiliation
Luciano G MartelottoThe University of Melbourne
Grant A McArthurPeter MacCallum Cancer Centre
Grant A McArthurThe University of Melbourne
Grant A McArthurPeter MacCallum Cancer Centre
Grant A McArthurThe University of Melbourne
Ricky W JohnstonePeter MacCallum Cancer Centre
Ricky W JohnstoneThe University of Melbourne
Karen E SheppardPeter MacCallum Cancer Centre
Karen E SheppardThe University of Melbourne
Karen E SheppardThe University of Melbourne
  • 1 - 10

Datasets

Release 1.2